Novel variant in IGHM gene in a patient with agammaglobulinemia: A case report of a preschool child presenting with recurrent pneumonia
Abstract
Introduction: Agammaglobulinemia is a primary immunodeficiency characterized by absent B cells and originates from X-linked or autosomal mutations affecting B cell maturation. While the most common agammaglobulinemia is X-linked, one well-documented site of autosomal recessive agammaglobulinemia is within the immunoglobulin μ heavy chain protein, encoded by the IGHM gene. Such variants frequently result in clinical presentations of recurrent bacterial infections early in life.
Aim: To describe a case of a five-year-old female with agammaglobulinemia resulting from a novel homozygous IGHM variant, presenting with pneumonia complicated by empyema and H. influenzae bacteremia.
Methods: Case data was compiled retrospectively from the patient’s medical chart, including relevant laboratory testing for immunoglobulins, quantitative B cell subsets, and genetic testing using a primary immunodeficiency panel.
Results: The proband is a 5-year-old female with a history of recurrent pneumonia, presenting with H. influenzae bacteremia in the context of pneumonia complicated by an empyema. Investigations revealed low immunoglobulin levels, absent vaccine responses, and undetectable B cells on flow cytometry. Genetic testing revealed a novel homozygous variant in the IGHM gene: c.775T>C, p.Trp259Arg.
Conclusion: Autosomal recessive agammaglobulinemia is a rare but severe, treatable disorder of the immune system which typically presents in early childhood. Hypomorphic mutations, while less commonly reported in the literature, are an important consideration in atypical presentations of primary immunodeficiencies, such as in the case presented.
Statement of Novelty: Herein, we report a case of agammaglobulinemia presenting with a novel homozygous variant in the IGHM gene leading to later onset agammaglobulinemia in a 5-year-old female.
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCES
Abbas, A.K., Lichtman, A.H., Pillai, S. 2021. Cellular and Molecular Immunology. 9th ed. Elsevier Canada, Canada .
Abolhassani H., Vitali M., Lougaris V., Giliani S., Parvaneh N., Parvaneh L., Mirminachi B., Cheraghi T., Khazaei H., Mahdaviani S.A., Kiaei F., Tavakolinia N., Mohammadi J., Negahdari B., Rezaei N., Hammarstrom L., Plebani A., and Aghamohammadi A. 2016. Cohort of iranian patients with congenital agammaglobulinemia: Mutation analysis and novel gene defects. Expert. Rev. Clin. Immunol. 12(4): 479–86.
Barreto I.C., Barreto B.A., Cavalcante E.G., and Condino Neto A. 2021. Immunological deficiencies: more frequent than they seem to be. J. de Pediatria. 97: 49–58.
Gagnier J.J., Kienle G., Altman D.G., Moher D., Sox H., and Riley D. 2013. CARE group*. The CARE guidelines: Consensus-based clinical case reporting guideline development. Glob. Adv. Health Med. 2(5):38–43.
Lopez Granados E., Porpiglia A.S., Hogan M.B., Matamoros N., Krasovec S., Pignata C., Smith C.I., Hammarstrom L., Bjorkander J., Belohradsky B.H., Casariego G.F., Garcia Rodriguez M.C., and Conley M.E. 2002. Clinical and molecular analysis of patients with defects in micro heavy chain gene. J. Clin. Invest. 110(7):1029–35.
Lougaris V., Soresina A., Baronio M., Montin D., Martino S., Signa S., Volpi S, Zecca M., Marinoni M., Baselli L.A., Dellepiane R.M., Carrabba M., Fabio G., Putti M.C., Cinetto F., Lunardi C., Gazzurelli L., Benvenuto A., Bertolini P., Conti F., Consolini R., Ricci S., Azzari C., Leonardi L., Duse M., Pulvirenti F., Milito C., Quinti I., Cancrini C., Finocchi A., Moschese V., Cirillo E., Crescenzi L., Spadaro G., Marasco C., Vacca A., Cardinale F., Martire B., Trizzino A., Licciardello M., Cossu F., Di, Matteo G., Badolato R., Ferrari S., Giliani S., Pession A., Ugazio A., Pignata C., and Plebani A. 2020. Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality. J Allergy Clin Immunol. 146(2):429–437.
Madathil Govindaraj G., Jain A., Edavazhippurath A., Bhoyar R.C., Dhanasooraj D., Mishra A., Gupta V., Nair M., Shiny P.M., Uppuluri R., Kumar A., Kashyap A., Ajith Kumar V.T., Shankaran G., Senthivel V., Imran M., Kumar Divakar M., Sawant S., Dalvi A., Madkaikar M., Raj R., Sivasubbu S., and Scaria V. 2022. Clinical, immunological and genomic characteristics of children with X-linked agammaglobulinemia from Kerala, South India. Hum Immunol. 83(4):335–345.
Milili M., Antunes H., Blanco-Betancourt C., Nogueiras A., Santos E., Vasconcelos J., Castro e Melo J., and Schiff C. 2002. A new case of autosomal recessive agammaglobulinaemia with impaired pre-B cell differentiation due to a large deletion of the IGH locus. Eur J Pediatr. 161(9):479–84.
Mohammadzadeh I., Yeganeh M., Aghamohammadi A., Parvaneh N., Behniafard N., Abolhassani H., Tabassomi F., Hemmat M., Kanegane H., Miyawaki T., Ohara O., and Rezaei N. 2012. Severe primary antibody deficiency due to a novel mutation of mu heavy chain. J. Investig Allergol Clin. Immunol. 22(1):78–9.
Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., Voelkerding K., and Rehm H.L. 2015. ACMG laboratory quality Assurance committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the association for molecular pathology. Genet. Med. 17(5):405–24.
Silva P, Justicia A, Regueiro A, Fariña S, Couselo JM, and Loidi L. 2017. Autosomal recessive agammaglobulinemia due to defect in μ heavy chain caused by a novel mutation in the IGHM gene. Genes. Immun. 18(3):197–199.
Tam J.S. and Routes J.M. 2013. Common variable immunodeficiency. Am. J. Rhinol. Allergy. 27(4):260–5.
Weaver, C., Murphy, K., Berg, L. 2017. Janeway’s Immunobiology. 9th ed, W.W. Norton & Company, New York.
Yel L., Minegishi Y., Coustan-Smith E., Buckley R.H., Trübel H., Pachman L.M., Kitchingman G.R., Campana D., Rohrer J., and Conley M.E. 1996. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N. Engl. J. Med. 335(20):1486–93.
Information & Authors
Information
Published In
LymphoSign Journal
e-First
Pages: 1 - 5
History
Received: 20 May 2024
Accepted: 10 June 2024
Accepted manuscript online: 22 August 2024
Version of record online: 17 October 2024
Copyright
© 2024.
Authors
Metrics & Citations
Metrics
Other Metrics
Citations
Cite As
Erin JoyHeifetz, Anahita DehmoobadSharifabadi, RaeBrager, and JennyGarkaby. Novel variant in IGHM gene in a patient with agammaglobulinemia: A case report of a preschool child presenting with recurrent pneumonia. LymphoSign Journal.
e-First
https://doi.org/10.14785/lymphosign-2024-0006
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
There are no citations for this item
View Options
Get Access
Login options
Check if you access through your login credentials or your institution to get full access on this article.
